Ultragenyx Pharmaceutical Inc. 4

Ultragenyx CFO Howard Horn sold 4,696 shares of common stock at about $24.92 per share, totaling roughly $117,000.

On August 3, 2026, Howard Horn, Chief Financial Officer of Ultragenyx Pharmaceutical Inc., sold 4,696 shares of the company’s common stock at an average price of approximately $24.92 per share for total proceeds of about $117,000, leaving him with direct ownership of 96,295 shares, which include shares underlying previously reported RSUs that remain subject to vesting conditions.

Filing Facts

CIK

1515673

Ticker

RARE

Form

4

Source Type

fda

Accession

0001193125-26-332536

Alert Tier

6